5 agosto 2014
Preventative treatment with a monthly dose of a newer antimalarial drug can reduce the risk of malarial infection among young children, according to a new study. The study finds that treating young children with dihydroartemisinin-piperaquine decreased their risk of contracting malaria.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/3v6AZ4Ob8Wg/140805150825.htm
